Worth Venture Partners’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-28,200
Closed -$26.5K 74
2024
Q2
$26.5K Buy
+28,200
New +$4.05M 0.2% 52
2023
Q4
Sell
-14,600
Closed -$63.4K 171
2023
Q3
$63.4K Buy
+14,600
New +$1.94M 0.04% 127
2022
Q4
Sell
-13,400
Closed -$15K 209
2022
Q3
$15K Buy
+13,400
New +$1.73M 0.01% 158
2022
Q2
Sell
-15,500
Closed -$1K 179
2022
Q1
$1K Buy
+15,500
New +$2.05M ﹤0.01% 146

Other funds holding XLV

Worth Venture Partners's XLV Position: Q1 2021 in Review

Worth Venture Partners sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q1 2021, closing a stake of 4,813 shares — an estimated $546K sold.

Worth Venture Partners first reported a position in XLV in Q1 2017 and held it in 16 quarters. The position peaked at $1.46M in Q2 2019. 1,181 funds tracked by Wall St. Rank hold XLV as of Q1 2021.

  • Worth Venture Partners reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q1 2021 after selling out during the quarter.
  • Worth Venture Partners sold 4,813 State Street Health Care Select Sector SPDR ETF shares in Q1 2021, an estimated $546K.
  • Worth Venture Partners first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2017 and held it in 16 quarters.
  • Worth Venture Partners's State Street Health Care Select Sector SPDR ETF position peaked at $1.46M in Q2 2019.
  • 1,181 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2021.

Based on Worth Venture Partners's 13F filing for Q1 2021, filed 17 May 2021.